Position in ZYME
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$285,579
+$12,017 QoQ
Shares Held
10,925
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JAMES INVESTMENT RESEARCH, INC. holds $6,027,353 across 7 Biotechnology names. ZYME ranks #4 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
26,578 | $2,080,260 | |
| 2 | INVA |
Innoviva, Inc.
|
81,609 | $1,853,340 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
17,122 | $1,488,757 | |
| 4 | ZYME |
Zymeworks Inc.
This page
|
10,925 | $285,579 | |
| 5 | 14,833 | $252,161 | |||
| 6 | IRD |
Opus Genetics, Inc.
|
16,364 | $67,256 | |
| 7 | 43,686 | $0 |
All Filings in ZYME
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,579 | 10,925 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $273,562 | 10,925 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $287,655 | 10,925 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $180,672 | 10,578 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $132,753 | 10,578 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $125,983 | 10,578 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $154,861 | 10,578 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $132,753 | 10,578 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $90,018 | 10,578 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $111,280 | 10,578 | Shares | Sole | 2024-05-01 | |
| No filing history on record for this holder in this stock. | ||||||